SiteOne Therapeutics competitors

SiteOne Therapeutics Competitors include U.S. Stem Cell, Cannabis Sativa, Pfenex and CEL-SCI.
Add company...
SiteOne Therapeutics
SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids
U.S. Stem Cell
U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Cannabis Sativa
Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
Pfenex
Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Founding Date
Founding Date
2010
Founding Date
N/A
Founding Date
2012
Founding Date
2009
Founding Date
1983
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bozeman, US HQ
Locations
Sunrise, US HQ
Locations
Mesquite, US HQ
Locations
San Diego, US HQ
Locations
Vienna, US HQ
Employees
Employees
N/A
Employees
3
Employees
2
Employees
649% decrease
Employees
43
Valuation ($)
Valuation ($)
N/A
Valuation ($)
9.5 m
Valuation ($)
56.8 m
Valuation ($)
158.9 m
Valuation ($)
80 m
Facebook likes
Facebook likes
N/A
Facebook likes
1.4 k
Facebook likes
10.9 k
Facebook likes
5.7 k
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
1.8 k
Twitter followers
107
Twitter followers
9.2 k
Twitter followers
188

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$5.5m (FY, 2017)
Revenue (est.)
$11.6k (FY, 2015)
Revenue (est.)
$28.8m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$1.9m (FY, 2017)
Cost of goods
$5.8k (FY, 2015)
Cost of goods
$5.2m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$3.6m (FY, 2017)
Gross profit
$5.8k (FY, 2015)
Gross profit
$23.6m (FY, 2017)
Gross profit
N/A
Net income
Net income
N/A
Net income
($3.5m) (FY, 2017)
Net income
($7.4m) (FY, 2015)
Net income
($25.7m) (FY, 2017)
Net income
($14.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 17.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 24m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

U.S. Stem Cell
HQ
Sunrise, US
Employees
3

U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

View company
Cannabis Sativa
HQ
Mesquite, US
Employees
2

Cannabis Sativa, Inc is engaged in the research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.

View company
Pfenex
HQ
San Diego, US
Employees
64↓ 9% decrease

Pfenex is a clinical-stage biotechnology company developing and commercializing high-value and difficult to manufacture proteins.

View company
CEL-SCI
HQ
Vienna, US
Employees
43

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

View company